Several researchers from the Reproductive Medicine Center of the Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University), or CQHCWC, in Southwest China's Chongqing, received invitations to attend the 39th Annual Meeting of the European Society for Human Reproduction and Embryology (ESHRE), which will be held on June 25-28 in Copenhagen, Denmark.

Among them, Dr Li Jingyu will present a report, Dr Lin Tingting and Dr Luo Yunyao will deliver speeches, and six researchers will showcase their works through wall posters.

The academic reports will cover clinical and basic research fields that are related to early embryonic metabolism and histone modification, gene regulation of male sperm development, the quality of aged oocytes, embryo transplantation, and so on. These reports will prove that not only is the CQHCWC's scientific research strength in the field of reproductive medicine on par with international standards, but that it is also recognized by global experts.

As an authoritative event in the field of reproductive medicine, the first annual ESHRE meeting was initiated in 1985, and it has since been engaged in promoting the development of clinical and basic research.

The international conference gathers the world's top experts and scholars in the fields of reproductive medicine, embryology, endocrinology, and genetics, to discuss the latest research achievements.

In 2019, a total of 12,003 attendees from more than 120 countries and regions attended the event, among which 429 were from China.

This year, the number of attendees from the CQHCWC that were invited to present a report at the conference reached an all-time high. This demonstrates the advanced diagnosis, treatment and research level of CQHCWC's Reproductive Medicine Center.

Brief introduction of the Reproductive Medicine Center of the CQHCWC

The Reproductive Medicine Center of the CQHCWC is the first reproductive center in the country to be approved by the former Ministry of Health – now known as the National Health Commission – to utilize human-assisted reproductive technology. It is also one of the few assisted reproductive technology training bases in the country.

The center was the first in West China to facilitate pregnancy through in vitro fertilization (IVF), and was the first to utilize intracytoplasmic sperm injection (ICSI) technology.

It ranked seventh among all Chinese hospitals in terms of reproductive medicine from 2017 to 2021, according to a list compiled by the Hospital Management Institute of Fudan University.

Its academic leader, Professor Huang Guoning, is the current chairman of the Reproductive Medicine Branch of the Chinese Medical Association, as well as the head of the Embryology Group. He has been awarded the "China's State Council Government Special Allowance", the "May Day Labor Medal", the title of "National Advanced Workers", among others.

Since the birth of the first "test-tube baby" in western China in 1997, the Reproductive Medicine Center of the CQHCWC has attached great importance to accelerating sci-tech innovation and offering better services to patients. It is also continuously improving its clinical and experimental technologies.

The center has been recognized as the Chongqing Reproductive Health and Infertility Medical Quality Control Center, the Chongqing Reproductive Medicine Clinical Medical Research Center, and the Chongqing Key Laboratory for Human Embryo Engineering. It currently offers related training to more than 2,000 medical workers nationwide.

To date, the Reproductive Medicine Center of the CQHCWC has facilitated more than 110,000 assisted pregnancies and helped birth to more than 60,000 "test-tube babies". Its clinical pregnancy rate is stable at over 60 percent, and its live birth rate remains at more than 50 percent–among the highest in the nation.